Disease Info Card

Peripheral Nerve Sheath Neoplasm

Information about Peripheral Nerve Sheath Neoplasm: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Peripheral Nerve Sheath Neoplasm

Most recent studies have shown that Peripheral Nerve Sheath Neoplasm shares some biological mechanisms with cell-transformation-neoplastic, histiocytoma-benign-fibrous, leiomyosarcoma, malignant-neoplasms, malignant-paraganglionic-neoplasm, malignant-peripheral-nerve-sheath-tumor, neoplasm-metastasis, neoplasms, nerve-sheath-tumors, nervousness, neurilemmoma, neurofibroma, neurofibromatoses, neurofibromatosis-1, peripheral-nervous-system-neoplasms, plexiform-neurofibroma, sarcoma, skin-neoplasms, soft-tissue-neoplasms, synovial-sarcoma.

Among the many pathways, these few ones have gauged particular interests from scientists studying Peripheral Nerve Sheath Neoplasm, and have been seen in publications frequently: Angiogenesis, Autophagy, Cell Adhesion, Cell Cycle, Cell Death, Cell Differentiation, Cell Growth, Cell Migration, Cell Proliferation, Interphase, Localization, Metaphase, Methylation, Mitosis, Muscle Atrophy, Pathogenesis, Regeneration, Reverse Transcription, Schwann Cell Proliferation

Quite a number of genes have been found to play important roles in Peripheral Nerve Sheath Neoplasm, such as B3GAT1, CD34, CDKN2A, DES, EGFR, GFAP, KIT, MUC1, NF1, NF2, NGFR, S100A1, S100B, SMARCB1, SS18L1, TP53, VIM. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.